116 related articles for article (PubMed ID: 38423596)
21. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
[TBL] [Abstract][Full Text] [Related]
22. Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients.
Kinker GS; Thomas AM; Carvalho VJ; Lima FP; Fujita A
Sci Rep; 2016 Apr; 6():24160. PubMed ID: 27052952
[TBL] [Abstract][Full Text] [Related]
23. The T-box transcription factor brachyury behaves as a tumor suppressor in gliomas.
Pinto F; Costa ÂM; Santos GC; Matsushita MM; Costa S; Silva VA; Miranda-Gonçalves V; Lopes CM; Clara CA; Becker AP; Neder L; Hajj GN; da Cunha IW; Jones C; Andrade RP; Reis RM
J Pathol; 2020 May; 251(1):87-99. PubMed ID: 32154590
[TBL] [Abstract][Full Text] [Related]
24. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
25. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
[TBL] [Abstract][Full Text] [Related]
26. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J
Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945
[TBL] [Abstract][Full Text] [Related]
27. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
28. Identification of PIEZO1 as a potential prognostic marker in gliomas.
Zhou W; Liu X; van Wijnbergen JWM; Yuan L; Liu Y; Zhang C; Jia W
Sci Rep; 2020 Sep; 10(1):16121. PubMed ID: 32999349
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.
Lin HH; Tsai WC; Tsai CK; Chen SH; Huang LC; Hueng DY; Hung KC
J Mol Neurosci; 2021 Aug; 71(8):1614-1621. PubMed ID: 33641091
[TBL] [Abstract][Full Text] [Related]
30. A network model of a cooperative genetic landscape in brain tumors.
Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI
JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L
Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679
[TBL] [Abstract][Full Text] [Related]
32. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Liu J; Li G
Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
[TBL] [Abstract][Full Text] [Related]
33. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
34. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
[TBL] [Abstract][Full Text] [Related]
35. Spalt-Like Transcription Factor 1 (SALL1) Gene Expression Inhibits Cell Proliferation and Cell Migration of Human Glioma Cells Through the Wnt/β-Catenin Signaling Pathway.
Chi D; Zhang W; Jia Y; Cong D; Hu S
Med Sci Monit Basic Res; 2019 May; 25():128-138. PubMed ID: 31040265
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
37. Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
Sun X; Liu X; Xia M; Shao Y; Zhang XD
J Transl Med; 2019 May; 17(1):159. PubMed ID: 31097021
[TBL] [Abstract][Full Text] [Related]
38. RPA3 promotes the proliferation, migration, and invasion of gliomas by activating the PI3K-AKT-mTOR pathway.
Liang L; Zhao Z; Jin Q; Zhang S; Zhao Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):80-86. PubMed ID: 37571896
[TBL] [Abstract][Full Text] [Related]
39. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in glioma.
Jiang X; Chen X; Huang X; Wang C; Wang C; Pan C; Cho WC; Nie Z; Pu J; Wang W
Aging (Albany NY); 2022 Jun; 14(19):7774-7793. PubMed ID: 35661004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
